Institution
German Red Cross
Healthcare•Berlin, Germany•
About: German Red Cross is a healthcare organization based out in Berlin, Germany. It is known for research contribution in the topics: Transplantation & Mesenchymal stem cell. The organization has 653 authors who have published 1146 publications receiving 40111 citations. The organization is also known as: Deutsches Rotes Kreuz & DRK.
Topics: Transplantation, Mesenchymal stem cell, Population, Stem cell, Antigen
Papers published on a yearly basis
Papers
More filters
TL;DR: Data indicate a specific interaction between ATXN2 expansions and the causes of ALS, possibly through altered RNA-processing as a common pathogenic factor.
70 citations
TL;DR: ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors and their implications for clinical practice are published.
Abstract: ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors
70 citations
TL;DR: Untreated CLL patients might constitute a challenge for long-lasting CART effects in vivo since only a low number of TN among the CART product could be generated.
Abstract: Introduction: Therapy with chimeric antigen receptor T (CART) cells for hematological malignancies has shown promising results. Effectiveness of CART cells may depend on the ratio of naive (T-N) vs ...
69 citations
TL;DR: Methylene blue/light treatment acts on HIV‐1 at different target sites: the envelope and core proteins, and the inner core structures RNA and RT and RT.
Abstract: In a photodynamic virus inactivation procedure for human fresh frozen plasma the plasma is exposed to visible light in the presence of 1 μM methylene blue This procedure is known to inactivate HIV-1 by at least 10632 TCID50/ml within 10 minutes To elucidate the mechanism of photo-dynamic inactivation of HIV-1 by methylene blue/light treatment, reverse transcriptase (RT), the HIV-1 associated protein p24, and viral RNA were examined In the dark, methylene blue up to 10 μM has no inhibitory effect on recombinant RT In the presence of light, recombinant RT inactivation was dependent on illumination time and the concentration of methylene blue After photoinactivation of the whole virus by methylene blue/light treatment, RT activity was also almost completely inhibited Simultaneously, it was found by Western blotting that HIV-1 p24 and gp120 are altered in size, possibly due to protein cross-linking In addition, it was shown by poly-merase chain reaction (PCR) inhibition assay that HIV-1 inactivation leads to destruction of its RNA In summary, methylene blue/light treatment acts on HIV-1 at different target sites: the envelope and core proteins, and the inner core structures RNA and RT © 1995 WiIey-Liss, Inc
69 citations
68 citations
Authors
Showing all 658 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Johannes Oldenburg | 72 | 583 | 18790 |
| Bodo Niggemann | 71 | 279 | 19475 |
| Norbert Weissmann | 71 | 384 | 21187 |
| Hubert Schrezenmeier | 69 | 360 | 16215 |
| Triantafyllos Chavakis | 65 | 242 | 13247 |
| Klaus Schwarz | 58 | 209 | 13407 |
| Willy A. Flegel | 50 | 233 | 6742 |
| Rainer M. Bohle | 49 | 235 | 6923 |
| Torsten Tonn | 48 | 151 | 11328 |
| Daniel Ricklin | 46 | 144 | 10713 |
| Erhard Seifried | 44 | 254 | 7967 |
| Pamela S. Becker | 42 | 257 | 6256 |
| Karen Bieback | 41 | 135 | 10010 |
| Halvard Bonig | 41 | 216 | 4828 |
| Julia Kzhyshkowska | 40 | 126 | 5963 |